Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab plus bevacizumab against sunitinib in untreated advanced renal cell carcinoma has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Sunitinib (sunitinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Cell Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2018-10-03